Distinct deposition of amyloid-β species in brains with Alzheimer’s disease pathology visualized with MALDI imaging mass spectrometry

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2051-5960

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Distinct deposition of amyloid-β species in brains with Alzheimer’s disease pathology visualized with MALDI imaging mass spectrometry ; volume:5 ; number:1 ; day:16 ; month:10 ; year:2017 ; pages:1-8 ; date:12.2017
Acta Neuropathologica Communications ; 5, Heft 1 (16.10.2017), 1-8, 12.2017

Classification: Biowissenschaften, Biologie

Keyword: Gehirn
Zentralnervensystem

Creator: Kakuda, Nobuto

Contributor: Miyasaka, Tomohiro
Iwasaki, Noriyuki
Nirasawa, Takashi
Wada-Kakuda, Satoko
Takahashi-Fujigasaki, Junko
Murayama, Shigeo
Ihara, Yasuo
Ikegawa, Masaya
SpringerLink (Online service)

DOI: 10.1186/s40478-017-0477-x

URN: urn:nbn:de:1111-2017121116729

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:22 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Kakuda, Nobuto
Miyasaka, Tomohiro
Iwasaki, Noriyuki
Nirasawa, Takashi
Wada-Kakuda, Satoko
Takahashi-Fujigasaki, Junko
Murayama, Shigeo
Ihara, Yasuo
Ikegawa, Masaya
SpringerLink (Online service)

Other Objects (12)

Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease

Nanoscale structure of amyloid-β plaques in Alzheimer’s disease

Co-aggregation with Apolipoprotein E modulates the function of Amyloid-β in Alzheimer’s disease

Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease

BMI1 is associated with CS8F amyloid-β and rates of cognitive decline in Alzheimer’s disease

Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer’s disease with APPdup and Down syndrome

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Myelin dysfunction drives amyloid-β deposition in models of Alzheimer’s disease

Alzheimer’s disease neuropathological change three decades after iatrogenic amyloid-β transmission

Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer’s Pathogenesis

Correction to: BMI1 is associated with CSF amyloid-β and rates of cognitive decline in Alzheimer’s disease

Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease

Nanoscale structure of amyloid-β plaques in Alzheimer’s disease

Co-aggregation with Apolipoprotein E modulates the function of Amyloid-β in Alzheimer’s disease

Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease

BMI1 is associated with CS8F amyloid-β and rates of cognitive decline in Alzheimer’s disease

Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer’s disease with APPdup and Down syndrome

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Myelin dysfunction drives amyloid-β deposition in models of Alzheimer’s disease

Alzheimer’s disease neuropathological change three decades after iatrogenic amyloid-β transmission

Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer’s Pathogenesis

Correction to: BMI1 is associated with CSF amyloid-β and rates of cognitive decline in Alzheimer’s disease

Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease

Nanoscale structure of amyloid-β plaques in Alzheimer’s disease

Co-aggregation with Apolipoprotein E modulates the function of Amyloid-β in Alzheimer’s disease

Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease

BMI1 is associated with CS8F amyloid-β and rates of cognitive decline in Alzheimer’s disease

Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer’s disease with APPdup and Down syndrome

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Myelin dysfunction drives amyloid-β deposition in models of Alzheimer’s disease

Alzheimer’s disease neuropathological change three decades after iatrogenic amyloid-β transmission

Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer’s Pathogenesis

Correction to: BMI1 is associated with CSF amyloid-β and rates of cognitive decline in Alzheimer’s disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Distinct deposition of amyloid-β species in brains with Alzheimer’s disease pathology visualized with MALDI imaging mass spectrometry

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease

Nanoscale structure of amyloid-β plaques in Alzheimer’s disease

Co-aggregation with Apolipoprotein E modulates the function of Amyloid-β in Alzheimer’s disease

Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease

BMI1 is associated with CS8F amyloid-β and rates of cognitive decline in Alzheimer’s disease

Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer’s disease with APPdup and Down syndrome

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Myelin dysfunction drives amyloid-β deposition in models of Alzheimer’s disease

Alzheimer’s disease neuropathological change three decades after iatrogenic amyloid-β transmission

Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer’s Pathogenesis

Correction to: BMI1 is associated with CSF amyloid-β and rates of cognitive decline in Alzheimer’s disease

Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease

Nanoscale structure of amyloid-β plaques in Alzheimer’s disease

Co-aggregation with Apolipoprotein E modulates the function of Amyloid-β in Alzheimer’s disease

Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease

BMI1 is associated with CS8F amyloid-β and rates of cognitive decline in Alzheimer’s disease

Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer’s disease with APPdup and Down syndrome

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Myelin dysfunction drives amyloid-β deposition in models of Alzheimer’s disease

Alzheimer’s disease neuropathological change three decades after iatrogenic amyloid-β transmission

Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer’s Pathogenesis

Correction to: BMI1 is associated with CSF amyloid-β and rates of cognitive decline in Alzheimer’s disease

Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease

Nanoscale structure of amyloid-β plaques in Alzheimer’s disease

Co-aggregation with Apolipoprotein E modulates the function of Amyloid-β in Alzheimer’s disease

Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease

BMI1 is associated with CS8F amyloid-β and rates of cognitive decline in Alzheimer’s disease

Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer’s disease with APPdup and Down syndrome

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Myelin dysfunction drives amyloid-β deposition in models of Alzheimer’s disease

Alzheimer’s disease neuropathological change three decades after iatrogenic amyloid-β transmission

Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer’s Pathogenesis

Correction to: BMI1 is associated with CSF amyloid-β and rates of cognitive decline in Alzheimer’s disease

Related objects

Reset password